Endocrine, Metabolic & Immune Disorders - Drug Targets

Author(s): Khashayar Danandeh, Parnian Jabbari, Elham Rayzan, Samaneh Zoghi, Sepideh Shahkarami, Raul Jimenez Heredia, Ana Krolo, Bibi Shahin Shamsian, Kaan Boztug and Nima Rezaei*

DOI: 10.2174/1871530322666220407091356

DownloadDownload PDF Flyer Cite As
Case Report of a Novel NFkB Mutation in a Lymphoproliferative Disorder Patient

Page: [1040 - 1046] Pages: 7

  • * (Excluding Mailing and Handling)

Abstract

Background: Lymphoproliferative disorders include a heterogeneous list of conditions that commonly involve dysregulation of lymphocyte proliferation resulting in lymphadenopathy and bone marrow infiltration. These disorders have various presentations, most notably autoimmune manifestations, organomegaly, lymphadenopathy, dysgammaglobulinemia, and increased risk of chronic infections.

Case Presentation: A young boy presented with symptoms overlapping different lymphoproliferative disorders, including episodes of chronic respiratory tract infections, dysgammaglobulinemia, lymphadenopathy-associated with splenomegaly as well as skin rashes. Genetic studies revealed multiple heterozygous variants, including a novel mutation in the NFκB1 gene.

Conclusion: This novel mutation can reveal new aspects in the pathogenesis of lymphoproliferative disorders and propose new treatments for them.

Keywords: Lymphoproliferative disorder, immunology, NFkB1, case report, autoimmune lymphoproliferative disorder, mutation, bone marrow infiltration.

Graphical Abstract